Fludarabine plus cyclophosphamide (FC) induces higher remission rates and longer progression free survival (PFS) than fludarabine (F) alone in first line therapy of advanced chronic lymphocytic leukemia (CLL): Results of a phase III study (CLL4 protocol)

Title:: Fludarabine plus cyclophosphamide (FC) induces higher remission rates and longer progression free survival (PFS) than fludarabine (F) alone in first line therapy of advanced chronic lymphocytic leukemia (CLL): Results of a phase III study (CLL4 protocol)
Document type:: Meeting Abstract
Author(s):: Eichhorst, BF; Busch, R; Hopfinger, G; Pasold, R; Hensel, M; Soling, U; Siehl, S; Steinbrecher, C; Jäger, U; Bergmann, M; Wendtner, CM; Hiddemann, W; Emmerich, B; Hallek, M
Journal title abbreviation:: Blood
Year:: 2003
Journal volume:: 102
Journal issue:: 11
Pages contribution:: 72A-72A
Language:: eng
Print-ISSN:: 0006-4971
TUM Institution:: Institut für Medizinische Statistik und Epidemiologie
BibTeX

Occurrences: